News
Nucala, FDA and GSK
Digest more
The U.S Food and Drug Administration has approved Nucala, British drugmaker GSK's asthma drug, to treat some patients with a ...
3hon MSN
GSK plc (NYSE:GSK) has strengthened its market outlook following major regulatory milestones. The U.S. FDA’s recent approval ...
While not the first biologic to break into the COPD sector – Sanofi and Regeneron took that crown with the approval of their ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.
At ATS 2025, data from the Phase III MATINEE trial reinforced the efficacy of Nucala in reducing exacerbations in COPD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results